Romanian Society of Pharmaceutical Sciences

« Back to Farmacia Journal 5/2012

THERAPEUTIC DRUG MONITORING OF CYCLOSPORINE IN TRANSPLANTED PATIENTS. POSSIBILITIES, CONTROVERSY, CAUSES FOR FAILURE

CAMIL-EUGEN VARI, AMELIA TERO-VESCAN*, SILVIA IMRE, DANIELA LUCIA MUNTEAN

Faculty of Pharmacy, University of Mecine and Pharmac Târgu-Mureş

Download Full Article PDF

Monitoring cyclosporine therapy is required by the narrow therapeutic index, high pharmacokinetic variability, the increased risk of drug interactions CYP 3A4- dependent and nephrotoxicity of the substance substance. The controversies raised by clinical practice are the best time of sampling, the analytical methods used and the feasibility of the pharmacokinetic models to estimate the useful concentrations for preventing rejection and nephrotoxicity, and inherent pharmacokinetic drug interactions with concomitant treatments.